Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lamont J Barlow

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Urology|April 26, 2022
EDITORIAL COMMENTLaMont J Barlow
Reviews in Urology|June 12, 2020
Non-muscle-invasive Bladder Cancer Management During BCG Shortages: NYU Case of the Month, February 2020LaMont J Barlow
Current Urology Reports|February 5, 2013
Experience with newer intravesical chemotherapy for high-risk non-muscle-invasive bladder cancerLaMont J Barlow, Mitchell C Benson
The Journal of Urology|August 10, 2021
Editorial CommentLaMont J Barlow, Gary D Steinberg
Cancer Cell|September 14, 2013
SnapShot: Prostate cancerLamont J Barlow, Michael M Shen
Urology|August 15, 2009
The case of a poorly differentiated gastric adenocarcinoma disguised as a testicular germ cell tumor in a 34-year-old maleLaMont J Barlow, Stephen A Poon, James M McKiernan
Nature Reviews. Urology|November 12, 2010
Serum tumor markers in the evaluation of male germ cell tumorsLaMont J Barlow, Gina M Badalato, James M McKiernan
World Journal of Urology|February 14, 2009
The novel use of intravesical docetaxel for the treatment of non-muscle invasive bladder cancer refractory to BCG therapy: a single institution experienceLamont J Barlow, James M McKiernan, Mitchell C Benson
The Journal of Urology|November 6, 2012
Long-term survival outcomes with intravesical docetaxel for recurrent nonmuscle invasive bladder cancer after previous bacillus Calmette-Guérin therapyLaMont J Barlow, James M McKiernan, Mitchell C Benson
BJU International|December 31, 2009
Predicting renal functional outcomes after surgery for renal cortical tumours: a multifactorial analysisLamont J Barlow, Ruslan Korets, Melissa Laudano, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Urology|April 26, 2022
EDITORIAL COMMENTLaMont J Barlow
Reviews in Urology|June 12, 2020
Non-muscle-invasive Bladder Cancer Management During BCG Shortages: NYU Case of the Month, February 2020LaMont J Barlow
Current Urology Reports|February 5, 2013
Experience with newer intravesical chemotherapy for high-risk non-muscle-invasive bladder cancerLaMont J Barlow, Mitchell C Benson
The Journal of Urology|August 10, 2021
Editorial CommentLaMont J Barlow, Gary D Steinberg
Cancer Cell|September 14, 2013
SnapShot: Prostate cancerLamont J Barlow, Michael M Shen
Urology|August 15, 2009
The case of a poorly differentiated gastric adenocarcinoma disguised as a testicular germ cell tumor in a 34-year-old maleLaMont J Barlow, Stephen A Poon, James M McKiernan
Nature Reviews. Urology|November 12, 2010
Serum tumor markers in the evaluation of male germ cell tumorsLaMont J Barlow, Gina M Badalato, James M McKiernan
World Journal of Urology|February 14, 2009
The novel use of intravesical docetaxel for the treatment of non-muscle invasive bladder cancer refractory to BCG therapy: a single institution experienceLamont J Barlow, James M McKiernan, Mitchell C Benson
The Journal of Urology|November 6, 2012
Long-term survival outcomes with intravesical docetaxel for recurrent nonmuscle invasive bladder cancer after previous bacillus Calmette-Guérin therapyLaMont J Barlow, James M McKiernan, Mitchell C Benson
BJU International|December 31, 2009
Predicting renal functional outcomes after surgery for renal cortical tumours: a multifactorial analysisLamont J Barlow, Ruslan Korets, Melissa Laudano, et al.
Pageof 3